High affinity human antibodies to human angiopoietin-2
US8987420B2 · kind B2 · utility
8Cited by
15References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 27, 2010 |
| Grant date | Mar 24, 2015 |
| Priority date | — |
| Expiry date | Dec 21, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides antibodies that bind to angiopoietin-2 (Ang-2) and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human Ang-2. The antibodies of the invention are useful, inter alia, for the treatment of diseases and disorders associated with one or more Ang-2 biological activities including angiogenesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.